Sabaté E. Adherence to long-term therapies: evidence for action. Geneva:World Health Organization; 2003.
Simpson SH, Eurich DT, Majumdar SR, Padwal RS, Tsuyuki RT, Varney J, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ 2006; 333: 15.
Shin S, Song H, Oh SK, Choi KE, Kim H, Jang S. Effect of antihypertensive medication adherence on hospitalization for cardiovascular disease and mortality in hypertensive patients. Hypertens Res 2013; 36: 1000-5.
Hong JS, Kang HC. Relationship between oral antihyperglycemic medication adherence and hospitalization, mortality, and healthcare costs in adult ambulatory care patients with type 2 diabetes in South Korea. Med Care 2011; 49: 378-84.
Ho PM, Bryson CL, Rumsfeld JS. Medication adherence: its importance in cardiovascular outcomes. Circulation 2009; 119: 3028-35.
Marcum ZA, Sevick MA, Handler SM. Medication nonadherence: a diagnosable and treatable medical condition. JAMA 2013; 309: 2105-6.
Iuga AO, McGuire MJ. Adherence and health care costs. Risk Manag Healthc Policy 2014; 7: 35-44.
Osterberg L, Blaschke T. Adherence to medication. N Engl J Med 2005; 353:487-97.
Park JH, Shin Y, Lee SY, Lee SI. Antihypertensive drug medication adherence and its affecting factors in South Korea. Int J Cardiol 2008; 128: 392-8.
Morin D, Mérineau-Côté J, Ouellette-Kuntz H, Tassé MJ, Kerr M. A comparison of the prevalence of chronic disease among people with and without intellectual disability. Am J Intellect Dev Disabil 2012; 117: 455-63.
Havercamp SM, Scandlin D, Roth M. Health disparities among adults with developmental disabilities, adults with other disabilities, and adults not reporting disability in North Carolina. Public Health Rep 2004; 119: 418-26.
Day SM, Strauss DJ, Shavelle RM, Reynolds RJ. Mortality and causes of death in persons with Down syndrome in California. Dev Med Child Neurol 2005; 47: 171-6.
Park JH, Park JH, Lee SY, Kim SY, Shin Y, Kim SY. Disparities in antihypertensive medication adherence in persons with disabilities and without disabilities:results of a Korean population-based study. Arch Phys Med Rehabil 2008; 89: 1460-7.
Zhang Y, Baik SH, Chang CC, Kaplan CM, Lave JR. Disability, race/ethnicity, and medication adherence among medicare myocardial infarction survivors. Am Heart J 2012; 164: 425-33.e4.
Disability rating table, Enforcement Rule of Welfare Act for the disabled [Internet]. Seoul: Korea Ministry of Government Legislation; 2015 [cited 2015 Aug 3].
Tajouri TH, Driver SL, Holmes DR Jr. 'Take as directed'--strategies to improve adherence to cardiac medication. Nat Rev Cardiol 2014; 11: 304-7.
Ferrucci L, Guralnik JM, Pahor M, Corti MC, Havlik RJ. Hospital diagnoses, Medicare charges, and nursing home admissions in the year when older persons become severely disabled. JAMA 1997; 277: 728-34.
Col N, Fanale JE, Kronholm P. The role of medication noncompliance and adverse drug reactions in hospitalizations of the elderly. Arch Intern Med 1990; 150: 841-5.
Coons SJ, Sheahan SL, Martin SS, Hendricks J, Robbins CA, Johnson JA. Predictors of medication noncompliance in a sample of older adults. Clin Ther 1994; 16: 110-7.
Balkrishnan R. Predictors of medication adherence in the elderly. Clin Ther 1998; 20: 764-71.
Kim TW. The poverty and inequality of disabled people. Health Welf Polic Forum 2010: 20-9.
Kennedy J, Erb C. Prescription noncompliance due to cost among adults with disabilities in the United States. Am J Public Health 2002; 92: 1120-4.
Park JH, Shin Y, Lee SY, Park JH. Antihypertensive drug medication adherence of people with disabilities and its affecting factors in Korea. J Prev Med Public Health 2007; 40: 249-58.